1. CagL from Helicobacter pylori has ADP-ribosylation activity and exerts partial protective efficacy in mice
- Author
-
Paolo Ruggiero, Maria Scarselli, Enrico Balducci, Laura Pancotto, and Eleonora Talluri
- Subjects
0301 basic medicine ,Biophysics ,Biochemistry ,Helicobacter Infections ,Microbiology ,law.invention ,Pathogenesis ,Mice ,03 medical and health sciences ,ADP-Ribosylation ,NAD+ Nucleosidase ,Bacterial Proteins ,law ,Animals ,Molecular Biology ,Gene ,ADP Ribose Transferases ,chemistry.chemical_classification ,Binding Sites ,030102 biochemistry & molecular biology ,biology ,Helicobacter pylori ,biology.organism_classification ,Vaccination ,Treatment Outcome ,030104 developmental biology ,Enzyme ,chemistry ,ADP-ribosylation ,Recombinant DNA ,Female ,Bacteria ,Protein Binding - Abstract
Mono ADP-ribosyltransferases are a class of functionally conserved enzymes present in prokaryotic and eukaryotic organisms. In prokaryotes, mono ADP-ribose transfer enzymes often represent a family of exotoxins that display activity in a variety of bacteria responsible for causing disease in plants and animals. A bioinformatic approach has allowed us to identify that CagL gene from some Helicobacter pylori strains shares a sequence pattern with ADP-ribosylating toxins of the CT-group. In this manuscript we show that recombinant CagL from Shi470 is catalytically active showing ADP-ribosyltransferase, NAD-glycohydrolase, and auto-ADP-ribosylation activities. This is the first time that a catalytically active member of the ADP-ribosyltransferase family is identified in Helicobacter pylori. This observation may lead to the discovery of novel functions exerted by CagL in the pathogenesis of Helicobacter pylori. Indeed, we have shown that vaccination with CagL has protective efficacy in mice indicating that CagL may be considered as potential component of a Helicobacter pylori vaccine.
- Published
- 2017
- Full Text
- View/download PDF